Roberta Vezza Alexander

495 total citations
18 papers, 307 citations indexed

About

Roberta Vezza Alexander is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, Roberta Vezza Alexander has authored 18 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 14 papers in Immunology and 7 papers in Nephrology. Recurrent topics in Roberta Vezza Alexander's work include Systemic Lupus Erythematosus Research (15 papers), Complement system in diseases (9 papers) and Renal Diseases and Glomerulopathies (7 papers). Roberta Vezza Alexander is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Complement system in diseases (9 papers) and Renal Diseases and Glomerulopathies (7 papers). Roberta Vezza Alexander collaborates with scholars based in United States, Canada and Italy. Roberta Vezza Alexander's co-authors include Arthur Weinstein, Debra Zack, Thierry Dervieux, Rosalind Ramsey‐Goldman, Ying Qu, Puja Chitkara, John Conklin, Cristina Arriens, Christopher Collins and Sonali Narain and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Journal of Immunological Methods.

In The Last Decade

Roberta Vezza Alexander

16 papers receiving 296 citations

Peers

Roberta Vezza Alexander

IMMUN

RHEUM

NEPHR

HEMAT

RNMI

Hee Jung Ryu South Korea

María Kourilovitch Ecuador

Kar Li Chan China

Griselda Galindo-Rodrı́guez Mexico

Maria C. Borrias Netherlands

J Estreicher Switzerland

M. D. Lockshin United States

G Barbano Italy

Caroline H. Siegel United States

Hee Jung Ryu South Korea

Roberta Vezza Alexander

92 ×0.4

IMMUN

191 ×1.0

RHEUM

30 ×0.4

NEPHR

41 ×0.9

HEMAT

12 ×0.3

RNMI

Citations per year, relative to Roberta Vezza Alexander Roberta Vezza Alexander (= 1×) peers Hee Jung Ryu

Countries citing papers authored by Roberta Vezza Alexander

Since Specialization

Citations

This map shows the geographic impact of Roberta Vezza Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Vezza Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Vezza Alexander more than expected).

Fields of papers citing papers by Roberta Vezza Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Vezza Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Vezza Alexander. The network helps show where Roberta Vezza Alexander may publish in the future.

Co-authorship network of co-authors of Roberta Vezza Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Vezza Alexander. A scholar is included among the top collaborators of Roberta Vezza Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Vezza Alexander. Roberta Vezza Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sun, Kai, Amanda M. Eudy, Megan E. B. Clowse, et al.. (2025). Relationship between hydroxychloroquine blood levels and lupus activity through the lens of the type 1 and type 2 lupus model: a cross-sectional study. Lupus Science & Medicine. 12(1). e001531–e001531.

Buhler, Katherine A, Hongshu Guan, Misti L. Paudel, et al.. (2024). Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies. Journal of Autoimmunity. 148. 103299–103299. 3 indexed citations

Gartshteyn, Yevgeniya, Michelle Petri, Vasileios C. Kyttaris, et al.. (2023). Role of Platelet‐Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus. Arthritis Care & Research. 75(10). 2088–2095. 1 indexed citations

Sciascia, Savino, et al.. (2022). Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d. Frontiers in Immunology. 13. 949919–949919. 4 indexed citations

Conklin, John, Peter Izmirly, H. Michael Belmont, et al.. (2022). Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE). Lupus Science & Medicine. 9(1). e000754–e000754. 2 indexed citations

Gartshteyn, Yevgeniya, Adam Mor, Daichi Shimbo, et al.. (2021). Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus. Clinical Immunology. 228. 108755–108755. 12 indexed citations

Weinstein, Arthur, Roberta Vezza Alexander, & Debra Zack. (2021). A Review of Complement Activation in SLE. Current Rheumatology Reports. 23(3). 16–16. 93 indexed citations

Alexander, Roberta Vezza, et al.. (2021). A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus. Lupus Science & Medicine. 8(1). e000528–e000528. 6 indexed citations

Ramsey‐Goldman, Rosalind, Roberta Vezza Alexander, John Conklin, et al.. (2021). A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus. ACR Open Rheumatology. 3(2). 116–123. 5 indexed citations

10.

Alexander, Roberta Vezza, et al.. (2020). Capillary Blood Levels of Hydroxychloroquine and Methotrexate Are Stable for up to 5 Years When Collected on Volumetric Absorptive Microsamplers. The Journal of Applied Laboratory Medicine. 6(4). 858–867. 5 indexed citations

11.

Qu, Ying, et al.. (2019). Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases. The Journal of Applied Laboratory Medicine. 4(1). 40–49. 9 indexed citations

12.

Wallace, Daniel J., Roberta Vezza Alexander, Arezou Khosroshahi, et al.. (2019). Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE. Lupus Science & Medicine. 6(1). e000349–e000349. 6 indexed citations

13.

Weinstein, Arthur, Daniel J. Wallace, Chaim Putterman, et al.. (2019). Cell bound complement activation products alone and in combination with low serum complement C3 or C4 have superior diagnostic performance in systemic lupus erythematosus. The Journal of Immunology. 202(1_Supplement). 182.8–182.8. 1 indexed citations

14.

Ramsey‐Goldman, Rosalind, Roberta Vezza Alexander, Elena Massarotti, et al.. (2019). Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus. Arthritis & Rheumatology. 72(1). 78–88. 29 indexed citations

15.

Dervieux, Thierry, et al.. (2017). Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus. Journal of Immunological Methods. 446. 54–59. 18 indexed citations

16.

Qu, Ying, et al.. (2017). Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients. Journal of Pharmaceutical and Biomedical Analysis. 140. 334–341. 62 indexed citations

17.

Ramsey‐Goldman, Rosalind, et al.. (2017). Cell-bound complement activation products in SLE. Lupus Science & Medicine. 4(1). e000236–e000236. 40 indexed citations

18.

Goldman, John A., et al.. (2016). The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. The Open Rheumatology Journal. 10(1). 71–80. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact